Literature DB >> 72777

Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins.

R F Kibler, R B Fritz, F Chou, N Y Peacocke, N M Brown, D E McFarlin.   

Abstract

Peptide C1 (residues 68-88) from GP and rat BP differ by a single amino acid interchange at residue 79. This residue is serine in GP C1 and threonine in rat C1. GP C1 was encephalitogenic in Le rats at doses as low as 15 ng. Rat C1 was encephalitogenic at doses of 1,500 ng or greater. LNC from rats challenged with 25 X 10(-4) micronmol of GP C1 and 250 X 10(-4) micronmol of rat C1 showed a proliferative response in vitro to both peptides, but in each instance the magnitude of the response was greater to the GP peptide. GP C1 also induced higher levels of circulating antibodies at 25 X 10(-4) micronmol, but the specificity of antibodies produced by the two peptides was the same. These results have been interpreted as indicating that the presence of serine at position 79 in GP C1 results in the stimulation of greater numbers of T cells involved in (a) the induction of EAE, (b) the in vitro proliferative response and (c) helper function in antibody production.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72777      PMCID: PMC2180966          DOI: 10.1084/jem.146.5.1323

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Radioimmunoassay of myelin basic protein in sodium sulfate.

Authors:  E D Day; O M Pitts
Journal:  Immunochemistry       Date:  1974-10

2.  Specific cleavage of the A1 protein from myelin with cathepsin D.

Authors:  S W Brostoff; W Reuter; M Hichens; E H Eylar
Journal:  J Biol Chem       Date:  1974-01-25       Impact factor: 5.157

3.  Myelin basic proteins of mammalian and submammalian vertebrates: encephalitogenic activities in guinea pigs and rats.

Authors:  R E Martenson; G E Deibler; M W Kies; S Levine; E C Alvord
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

4.  Amino acid sequence of the smaller basic protein from rat brain myelin.

Authors:  P R Dunkley; P R Carnegie
Journal:  Biochem J       Date:  1974-07       Impact factor: 3.857

5.  Basis of microheterogeneity of myelin basic protein.

Authors:  F C Chou; C H Chou; R Shapira; R F Kibler
Journal:  J Biol Chem       Date:  1976-05-10       Impact factor: 5.157

6.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

7.  Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides.

Authors:  D E McFarlin; S E Blank; R F Kibler; S McKneally; R Shapira
Journal:  Science       Date:  1973-02-02       Impact factor: 47.728

8.  Large peptides of bovine and guinea pig myelin basic proteins produced by limited peptic hydrolysis.

Authors:  R E Martenson; A J Kramer; G E Deibler
Journal:  Biochemistry       Date:  1975-03-11       Impact factor: 3.162

9.  Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease production.

Authors:  L E Spitler; C M Von Muller; H H Fudenberg; E H Eylar
Journal:  J Exp Med       Date:  1972-07-01       Impact factor: 14.307

10.  Cellular events in the induction of experimental allergic encephalomyelitis in rats.

Authors:  L Ortiz-Ortiz; W O Weigle
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

View more
  17 in total

1.  Contrasting immunopathogenic properties of highly homologous peptides from rat and human thyroglobulin.

Authors:  V P Rao; G Carayanniotis
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 2.  Homeostatic control of immunity by TCR peptide-specific Tregs.

Authors:  Vipin Kumar
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.

Authors:  Anne I Boullerne; Jose J Rodriguez; Tarik Touil; Bruno Brochet; Stephan Schmidt; Nora D Abrous; Michel Le Moal; Jeffrey R Pua; Mark A Jensen; Willy Mayo; Barry G W Arnason; Klaus G Petry
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

4.  Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.

Authors:  Y Matsumoto; K Kawai; Y Tomita; M Fujiwara
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

Review 5.  T cell repertoire and autoimmune diseases.

Authors:  L Imberti; A Sottini; D Primi
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 6.  Transgenic mouse models of multiple sclerosis.

Authors:  Tanja Scheikl; Béatrice Pignolet; Lennart T Mars; Roland S Liblau
Journal:  Cell Mol Life Sci       Date:  2010-08-17       Impact factor: 9.261

7.  An experimental model of autoimmune pancreatitis in the rat.

Authors:  Todd S Davidson; Daniel S Longnecker; William F Hickey
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Equilibrium and nonequilibrium competitive inhibitions of antipeptide antibody binding by parent myelin basic protein and 18 related peptide sequences.

Authors:  E D Day; G A Hashim; V A Varitek; P Y Paterson
Journal:  Neurochem Res       Date:  1981-05       Impact factor: 3.996

9.  Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes.

Authors:  M D Mannie; P Y Paterson; D C U'Prichard; G Flouret
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

10.  In healthy primates, circulating autoreactive T cells mediate autoimmune disease.

Authors:  C P Genain; D Lee-Parritz; M H Nguyen; L Massacesi; N Joshi; R Ferrante; K Hoffman; M Moseley; N L Letvin; S L Hauser
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.